The takeaway
Review of migraine treatment advances covers anti-CGRP therapies, gepants, ditans, and emerging targets for comprehensive migraine management.
Key findingReview of migraine treatment advances covers anti-CGRP therapies, gepants, ditans, and emerging targ
What the researchers found
Review of migraine treatment advances covers anti-CGRP therapies, gepants, ditans, and emerging targets for comprehensive migraine management.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
Review of migraine treatment advances covers anti-CGRP therapies, gepants, ditans, and emerging targets for comprehensive migraine management.
How reliable?
Consult publication.
Read the original research
Migraine: advances in treatment.
Trends in molecular medicine
Citation
Ashraf, Usman; Goadsby, Peter J. (2025). Migraine: advances in treatment.. Trends in molecular medicine. https://doi.org/10.1016/j.molmed.2025.08.009